Wellinks

Wellinks is a Health Care startup founded in 2014 and headquartered in the United States. The company's slogan "Reinventing COPD Care Around The People Who Need It" encapsulates its focus on personalized care for individuals with COPD. Wellinks offers disease management programs tailored to the unique needs of each member, extending the reach of existing care resources and filling gaps where they are absent. Through one-on-one interactions with respiratory specialists and health coaches, as well as a community-based approach, Wellinks aims to personalize the COPD care experience and empower individuals in their journey to better health. The company's suite of innovative and user-friendly technologies, including connected devices and the Wellinks app, enables patients to manage their COPD from anywhere, bridging the gap between doctor visits. The recent $25.00M Series C investment received on 03 November 2021 has been from a consortium of investors including Connecticut Innovations, Morningside Ventures, Stonehenge Capital Company, HighCape Partners, and Benslie Investment Group. This significant funding reflects investor confidence in Wellinks' innovative approach to COPD care and its potential for long-term success. Wellinks' inclusive and empowering solution fosters a welcoming environment where members trust they will receive the best possible care and guidance in managing their COPD. The company's intuitive and fully integrated approach aims to empower patients with peace of mind and the freedom to live fully and breathe freely.